Liver Disease
MSC Transfusion Is Safe And Improves Liver Function In Acute-on-Chronic Liver Failure Patients
Let's take a look at the attached clinical summary, which highlights the promise of Mesenchymal Stem Cells (MSCs) in treating Acute-on-Chronic Liver Failure (ACLF) . In this study, a total of 24 patients were treated with UC-MSC transfusions, and a significant increase in survival rates for ACLF patients was observed.
Improvement Of Liver Function In Liver Cirrhosis Patients After Autologous MSC Injection
Liver cirrhosis treatment with autologous MSCs injection has shown promising results. 👍 This well-tolerated intervention has led to improvements in liver function, enabling patients to lead independent lives.
Undiff. versus diff. autologous MSC transplantation in patients with HCV liver cirrhosis
In this article, the comparison between undifferentiated and differentiated autologous MSC transplantation in HCV-induced liver cirrhosis patients revealed no significant difference. However, compared to the control group, the improvements in clinical manifestations, attributed to the antifibrotic effects of MSCs was observed. 🔍
Transplantation With Autologous Bone Marrow-Derived MSC For Alcoholic Cirrhosis
The article sharing here presents a compelling finding: liver cirrhosis, resulting from excessive alcohol consumption, may be treatable through the transplantation of autologous bone marrow MSCs. Each treatment session demonstrated a reduction in fibrosis without diminishing the treatment's efficacy.